Topic Editors

Department of Agricultural, Food and Environment, University of Catania, 95123 Catania, Italy
Department of Food Science, College of Agriculture and Veterinary Medicine, United Arab Emirates University (UAEU), Al Ain P.O. Box 15551, United Arab Emirates

News and Updates on Probiotics

Abstract submission deadline
30 September 2025
Manuscript submission deadline
31 December 2025
Viewed by
1647

Topic Information

Dear Colleagues,

Probiotics are commonly recognized as functional microorganisms that are able to exert a positive effect on human health. Although both the mechanism of action and the effect of pathogens on human hosts have been extensively studied, the attention of the scientific community has only recently shifted towards the beneficial role played by microorganisms with probiotic features. Increasing evidence demonstrates that microorganisms with claimed probiotic properties could benefit human (in different age groups) and animal health by modulating the host’s metabolism, physiology, nutrition, and immune functions. In addition, based on the available literature, probiotics have emerged as agents that are able not only to maintain a healthy status but also to prevent and treat dysbiosis. The Topic “News and Updates of Probiotics" aims at increasing knowledge about probiotic functions; molecular mechanisms of the host-microbe interactions that enable beneficial outcomes; identification, characterization, and the mechanisms of action of bioactive molecules produced by probiotics; and the development of innovative strategies for the prevention and treatment of diseases and dysbiosis. This Topic plans to publish original basic research articles, clinical studies, reviews, and perspectives that contribute to understanding probiotics, their mechanisms of action, health benefits, and applications in various fields. Potential topics include (but are not limited to) the following:

  • Isolation, identification, and characterization of new probiotic strains;
  • Studying the mechanisms of action by which probiotics exert health-promoting effects on the host, including interactions with microbiota, modulation of the immune function, and production of bioactive compounds;
  • Clinical trials and epidemiological studies investigating the health effects of probiotics in the prevention and treatment of various dysbiosis and pathologic conditions as well as in improving animal health, growth performance, and disease resistance;
  • Development of probiotic-containing foods, beverages, and dietary supplements for human and animal consumption;
  • Development of probiotics for soil and plant health.

Dr. Alessandra Pino
Dr. Mutamed Ayyash
Topic Editors

Keywords

  • probiotics
  • prebiotics
  • gut microbiota
  • human health
  • host-microbe interactions
  • diseases and dysbiosis
  • probiotic-containing foods, beverages, and dietary supplements

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Applied Microbiology
applmicrobiol
- 2.8 2021 13.3 Days CHF 1200 Submit
Fermentation
fermentation
3.3 5.7 2015 15.5 Days CHF 2100 Submit
Foods
foods
5.1 8.7 2012 14.9 Days CHF 2900 Submit
Microbiology Research
microbiolres
2.2 2.8 2010 20.7 Days CHF 1600 Submit
Microorganisms
microorganisms
4.2 7.7 2013 15.2 Days CHF 2700 Submit
Nutrients
nutrients
5.0 9.1 2009 12.9 Days CHF 2900 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (1 paper)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
19 pages, 1446 KiB  
Review
Postbiotics Derived from Lactic Acid Bacteria Fermentation: Therapeutic Potential in the Treatment of Muscular Complications in Inflammatory Bowel Disease
by Emili Bruna Toso Bueno, Kimberlly de Oliveira Silva, Maria Eduarda Ferraz Mendes, Lívia Batista de Oliveira, Felipe Prado de Menezes, Anna Cardoso Imperador, Lucimeire Fernandes Correia and Lizziane Kretli Winkelstroter
Fermentation 2025, 11(7), 362; https://doi.org/10.3390/fermentation11070362 - 23 Jun 2025
Viewed by 504
Abstract
Inflammatory bowel disease (IBD) is characterized by chronic inflammation in the gastrointestinal tract, which can result in several muscular complications, including sarcopenia, the loss of muscle mass, and impaired muscle function. Recently, postbiotics derived from lactic bacteria, such as Lactobacillus and Bifidobacterium, [...] Read more.
Inflammatory bowel disease (IBD) is characterized by chronic inflammation in the gastrointestinal tract, which can result in several muscular complications, including sarcopenia, the loss of muscle mass, and impaired muscle function. Recently, postbiotics derived from lactic bacteria, such as Lactobacillus and Bifidobacterium, have emerged as potential therapeutic modulators for these complications. Postbiotics are bioactive metabolites, such as short-chain fatty acids (SCFAs), antimicrobial peptides, and other compounds produced by microorganisms during fermentation, which have anti-inflammatory, antioxidant, and metabolic regulatory effects. These metabolites are important due to their potential to positively influence muscle health in patients with IBD, mainly by reducing systemic and local inflammation, improving gut microbiota, and modulating muscle metabolism. Studies suggest that these postbiotics may help minimize muscle degradation and promote muscle tissue regeneration, assisting in the prevention or management of IBD-associated sarcopenia. Despite the promising results, challenges remain, such as variability in postbiotic production and the need for further clinical studies to establish clear therapeutic guidelines. This review article explores the mechanisms of action of postbiotics derived from lactic acid bacteria and their potential applications in the treatment of muscle complications in patients with IBD, highlighting future therapeutic perspectives. Full article
(This article belongs to the Topic News and Updates on Probiotics)
Show Figures

Figure 1

Back to TopTop